• 1
    Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001; 121: 71023.
  • 2
    Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37: 91723.
  • 3
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346: 122131.
  • 4
    Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987; 10: 51216.
  • 5
    Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005; 2: 519.
  • 6
    Anurag P, Anuradha CV. Effect of metformin on blood pressure, insulin sensitivity and protein bound sugars in fructose induced hypertensive rats. Med Sci Res. 1999; 27: 10712.
  • 7
    Armutcu F, Coskun O, Gurel A. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose induced steatohepatitis in rats. Clin Biochem. 2005; 38: 5407.
  • 8
    Kelley GL, Allan G, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology. 2004; 145: 54855.
  • 9
    Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998; 68(Suppl.): 1333S46S.
  • 10
    Yousef MI, Kamel KI, Esmail AM, Baghdade HH. Antioxidant activities and lipid lowering effect of isoflavone in male rabbits. Food Chem Toxicol. 2004; 42: 1497503.
  • 11
    Azadbakht L, Shakerhosseini R, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr. 2003; 57: 12924.
  • 12
    Palanisamy N, Viswanathan P, Anuradha CV. Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Ren Fail. 2008; 30: 64554.
  • 13
    Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226: 497509.
  • 14
    Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Cardiac lipids and antioxidant status in high fructose rats and the effect of α-lipoic acid. Nutr Metab Cardiovasc Dis. 2004; 14: 3517.
  • 15
    Wilson DE, Spiger MJ. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J Lab Clin Med. 1973; 82: 47382.
  • 16
    Niehaus WG Jr, Samuelsson B. Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968; 6: 12630.
  • 17
    Jiang Z, Hunt J, Wolff S. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem. 1992; 202: 3849.
  • 18
    Levine RL, Garland D, Oliver CNL. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990; 186: 46478.
  • 19
    Nandhini AT, Balakrishnan SD, Anuradha CV. Response of liver antioxidant system to taurine in rats fed high fructose diet. Indian J Exp Biol. 2002; 40: 101669.
  • 20
    Rock E, Astier C, Lab C, Malpuech C. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes Res. 1995; 8: 23742.
  • 21
    Cook JA, Kim SY, Teague D. Convenient colorimetric and fluorometric assays for S-Nitrosothiols. Anal Biochem. 1996; 238: 1508.
  • 22
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol reagent. J Biol Chem. 1951; 193: 26575.
  • 23
    Varley H. Practical Clinical Biochemistry, 4th edn. CBS Publishers and distributors, New Delhi (India), 2004; 23073.
  • 24
    Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med. 1993; 14: 287371.
  • 25
    Martins AM, Cordeiro C, Freire AP. Glyoxalase II in Saccharomyces cerevisae: in situ kinetics using the 5′,5′-dithiobis(2-nitrobenzoic acid) assay. Arch Biochem Biophys. 1999; 366: 1520.
  • 26
    Liener IE, Schultze MO. Liver arginase activity as related to blood urea in acute uremia of new-born rats. J Biol Chem. 1950; 187(2): 74350.
  • 27
    Delbosc S, Paizanis E, Magous R. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis. 2005; 179: 439.
  • 28
    Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr. 1997; 127: 1037.
  • 29
    Greenacre SAB, Ishiropoulos H. Tyrosine nitration: localization, quantification, consequences for protein functions and signal transduction. Free Radic Res. 2001; 34: 54181.
  • 30
    Thornalley PJ. Methyl glyoxal, glyoxalases and the development of diabetic complications. Amino Acids. 1994; 6: 1523.
  • 31
    Vanithadevi B, Anuradha CV. Effect of rosmarinic acid on insulin sensitivity, glyoxalase system and oxidative events in liver of fructose-fed mice. Int J Diabetes & Metabolism. 2008; 16: 3342.
  • 32
    Miller A, Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol. 2008; 24: 2049.
  • 33
    Jurgens H, Haas W, Castanedana TR. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res. 2005; 13: 114656.
  • 34
    Akiyama T, Ishida J, Nakagawa S et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262: 55926.
  • 35
    McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutr Cancer. 2007; 57: 18493.
  • 36
    Min JY, Liao H, Wang JF, Sullivan MF, Ito T, Morgan JP. Genistein attenuates postischemic depressed myocardial function by increasing myofilament Ca2+sensitivity in rat myocardium. Exp Biol Med (Maywood). 2002; 227: 6328.
  • 37
    Bitto A, Polito F, Burnett B et al. Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats. J Endocrinol. 2009; 201: 3218.
  • 38
    Kapiostis S, Hermann M, Held I, Seelos C, Ehringer H, Gmeiner BM. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protect endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol. 1997; 17: 286874.
  • 39
    Cai Q, Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer. 1996; 25: 17.
  • 40
    Wang J, Mazza G. Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-γ-activated RAW 264.7 macrophages. J Agric Food Chem. 2002; 50: 8507.
  • 41
    Szkudelska K, Nogowski L. Genistein: a dietary compound inducing hormonal and metabolic changes. J Steroid Biochem Mol Biol. 2007; 105: 3745.
  • 42
    Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A. 1998; 95: 310610.
  • 43
    Harmon A, Patel Y, Harp J. Genistein inhibits CCAAT/enhancer-binding protein beta activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J. 2002; 367: 2038.
  • 44
    Kim S, Shin HJ, Kim SY et al. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR α. Mol Cell Endocrinol. 2004; 220: 518.
  • 45
    Yalniz M, Bahcecioglu IH, Kuzu N et al. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol. 2007; 22: 200914.
  • 46
    Gudbrandsen OA, Wergedahl H, Berge RK. A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats. Nutrition. 2009; 25: 57480.